• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉痉挛性心绞痛患者血浆硫氧还蛋白水平升高。

Increased plasma levels of thioredoxin in patients with coronary spastic angina.

作者信息

Miyamoto Shinzo, Kawano Hiroaki, Sakamoto Tomohiro, Soejima Hirofumi, Kajiwara Ichiro, Hokamaki Jun, Hirai Nobutaka, Sugiyama Seigo, Yoshimura Michihiro, Yasue Hirofumi, Nakamura Hajime, Yodoi Junji, Ogawa Hisao

出版信息

Antioxid Redox Signal. 2004 Feb;6(1):75-80. doi: 10.1089/152308604771978363.

DOI:10.1089/152308604771978363
PMID:14713337
Abstract

To determine whether plasma levels of thioredoxin are associated with coronary spasm, we measured the plasma levels of thioredoxin in 170 patients who had <25% organic stenosis in coronary arteriography. According to the results of cardiac catheterization, we divided the patients into two groups: a coronary spastic angina group (n=84) and a chest pain syndrome group (n=86). The plasma levels of thioredoxin were significantly higher in the coronary spastic angina group than in the chest pain syndrome group (40.7 +/- 4.1 versus 18.2 +/- 1.1 ng/ml, p<0.0001). Furthermore, the increased plasma levels of thioredoxin were associated with high disease activity indicated by the frequency of angina attacks (p=0.0004). In multiple logistic regression analysis, the higher levels of thioredoxin [relative risk 14.8, 95% confidence interval (5.13-42.9), p<0.0001] and current smoking [relative risk 3.39, 95% confidence interval (1.31-8.75), p=0.012] were significant and independent variables associated with coronary spasm. We demonstrated that the plasma levels of thioredoxin were increased in the coronary spastic angina group, and increased levels of thioredoxin were associated with high disease activity. The plasma levels of thioredoxin and current smoking were risk factors for coronary spastic angina, and they were independent from other traditional risk factors.

摘要

为了确定血浆硫氧还蛋白水平是否与冠状动脉痉挛有关,我们测量了170例冠状动脉造影显示有机狭窄<25%的患者的血浆硫氧还蛋白水平。根据心脏导管检查结果,我们将患者分为两组:冠状动脉痉挛性心绞痛组(n = 84)和胸痛综合征组(n = 86)。冠状动脉痉挛性心绞痛组的血浆硫氧还蛋白水平显著高于胸痛综合征组(40.7±4.1对18.2±1.1 ng/ml,p<0.0001)。此外,血浆硫氧还蛋白水平的升高与心绞痛发作频率所表明的高疾病活动度相关(p = 0.0004)。在多因素逻辑回归分析中,硫氧还蛋白水平较高[相对风险14.8,95%置信区间(5.13 - 42.9),p<0.0001]和当前吸烟[相对风险3.39,95%置信区间(1.31 - 8.75),p = 0.012]是与冠状动脉痉挛相关的显著且独立的变量。我们证明冠状动脉痉挛性心绞痛组的血浆硫氧还蛋白水平升高,且硫氧还蛋白水平升高与高疾病活动度相关。血浆硫氧还蛋白水平和当前吸烟是冠状动脉痉挛性心绞痛的危险因素,且它们独立于其他传统危险因素。

相似文献

1
Increased plasma levels of thioredoxin in patients with coronary spastic angina.冠状动脉痉挛性心绞痛患者血浆硫氧还蛋白水平升高。
Antioxid Redox Signal. 2004 Feb;6(1):75-80. doi: 10.1089/152308604771978363.
2
Vitamin E improves fibrinolytic activity in patients with coronary spastic angina.
Thromb Res. 2004;113(6):345-51. doi: 10.1016/j.thromres.2004.03.016.
3
Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina.不稳定型心绞痛患者和冠状动脉痉挛性心绞痛患者的血浆纤溶酶原激活物抑制剂活性及组织型纤溶酶原激活物水平
Am Heart J. 1992 Aug;124(2):314-9. doi: 10.1016/0002-8703(92)90592-j.
4
Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction.
Am Heart J. 2003 Sep;146(3):465-71. doi: 10.1016/S0002-8703(03)00311-9.
5
Association of the serum apolipoprotein levels with the occurrence of coronary vasospasm.
Coron Artery Dis. 2011 May;22(3):125-30. doi: 10.1097/MCA.0b013e328341baa9.
6
Plasma thioredoxin levels in patients with unstable angina.不稳定型心绞痛患者的血浆硫氧还蛋白水平
Int J Cardiol. 2005 Mar 18;99(2):225-31. doi: 10.1016/j.ijcard.2004.01.010.
7
[Coronary arterial spasm and symptomatology in ischemic and non-ischemic heart diseases: study of the ergonovine maleate provocative test in 3,000 consecutive patients].[缺血性和非缺血性心脏病中的冠状动脉痉挛及症状学:对连续3000例患者进行的马来酸麦角新碱激发试验研究]
J Cardiogr Suppl. 1987;12:35-47.
8
Increased plasma thioredoxin in patients with acute myocardial infarction.急性心肌梗死患者血浆硫氧还蛋白水平升高。
Clin Cardiol. 2003 Dec;26(12):583-7. doi: 10.1002/clc.4960261208.
9
Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina.冠状动脉痉挛性心绞痛患者血清硫氧还蛋白水平升高,氧化应激增加。
Clin Cardiol. 2003 Apr;26(4):177-81. doi: 10.1002/clc.4960260406.
10
An increased monocyte count predicts coronary artery spasm in patients with resting chest pain and insignificant coronary artery stenosis.单核细胞计数增加预示着静息性胸痛且冠状动脉狭窄不明显患者会发生冠状动脉痉挛。
Korean J Intern Med. 2006 Jun;21(2):97-102. doi: 10.3904/kjim.2006.21.2.97.

引用本文的文献

1
Coronary Artery Spasm: From Physiopathology to Diagnosis.冠状动脉痉挛:从病理生理学到诊断
Life (Basel). 2025 Apr 3;15(4):597. doi: 10.3390/life15040597.
2
Cellular Mechanisms of Coronary Artery Spasm.冠状动脉痉挛的细胞机制
Biomedicines. 2022 Sep 21;10(10):2349. doi: 10.3390/biomedicines10102349.
3
An Evaluation of the Role of Oxidative Stress in Non-Obstructive Coronary Artery Disease.氧化应激在非阻塞性冠状动脉疾病中的作用评估
J Cardiovasc Dev Dis. 2022 Feb 4;9(2):51. doi: 10.3390/jcdd9020051.
4
The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy.左卡尼汀治疗肝硬化但无显性肝性脑病患者疲劳的疗效。
Intern Med. 2021;60(22):3533-3542. doi: 10.2169/internalmedicine.7175-21. Epub 2021 Nov 15.
5
Atypical antipsychotics and oxidative cardiotoxicity: review of literature and future perspectives to prevent sudden cardiac death.非典型抗精神病药物与氧化心脏毒性:文献综述及预防心源性猝死的未来展望
J Geriatr Cardiol. 2021 Aug 28;18(8):663-685. doi: 10.11909/j.issn.1671-5411.2021.08.002.
6
Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration.顺铂耐药性与氧化还原代谢脆弱性:第二个改变。
Int J Mol Sci. 2021 Jul 9;22(14):7379. doi: 10.3390/ijms22147379.
7
A pathophysiological compass to personalize antianginal drug treatment.一种病理生理学指南针,用于个性化抗心绞痛药物治疗。
Nat Rev Cardiol. 2021 Dec;18(12):838-852. doi: 10.1038/s41569-021-00573-w. Epub 2021 Jul 7.
8
Coronary Artery Spasm: New Insights.冠状动脉痉挛:新的认识。
J Interv Cardiol. 2020 May 14;2020:5894586. doi: 10.1155/2020/5894586. eCollection 2020.
9
The Biochemical Markers Associated with the Occurrence of Coronary Spasm.与冠状动脉痉挛发生相关的生化标志物。
Biomed Res Int. 2019 Sep 17;2019:4834202. doi: 10.1155/2019/4834202. eCollection 2019.
10
Coronary artery spasm - Clinical features, pathogenesis and treatment.冠状动脉痉挛——临床特征、发病机制与治疗。
Proc Jpn Acad Ser B Phys Biol Sci. 2019;95(2):53-66. doi: 10.2183/pjab.95.005.